Clinical Training and Clerkship Experience

During his Master’s training in Clinical Pharmacy at Universiti Sains Malaysia, Dr. Muhammad Zeeshan Munir completed structured clinical clerkships at Penang General Hospital. The clinical rotations were designed to provide hands-on exposure to multidisciplinary patient care and evidence-based pharmacotherapy across several medical specialties.

Dr. Munir completed clinical placements of approximately three weeks in each ward and was actively involved in reviewing medication regimens, identifying drug-related problems, participating in clinical discussions, and developing pharmacotherapeutic care plans under the supervision of clinical pharmacists and physicians.

His clinical training included rotations in the following departments:

Intensive Care Unit (ICU)

Managed complex critical care cases including cardiogenic shock, infective endocarditis, melioidosis, and septic shock. The training involved therapeutic drug monitoring, optimization of antimicrobial therapy, and evaluation of organ dysfunction–related pharmacotherapy adjustments.

Infectious Diseases Unit

Exposure to management of infectious diseases such as aspiration pneumonia, Burkholderia cepacia sepsis, gangrenous infections, and retroviral disease. The focus was on antimicrobial stewardship, infectious disease pharmacotherapy, and evaluation of drug resistance patterns.

Oncology Department

Clinical management of chemotherapy-related complications including radiation-induced nausea and vomiting (RINV), chemotherapy-induced nausea and vomiting (CINV), cisplatin-induced nephrotoxicity, and opportunistic infections such as Pneumocystis pneumonia (PCP).

Internal Medicine (Medical Wards I & II)

Clinical assessment and pharmacotherapeutic management of cases such as over-warfarinization, hypoglycemia, acute kidney injury, acute ischemic stroke, persistent atrial fibrillation, NSTEMI, chronic kidney disease, and cardiomyopathy.

Pediatrics Department

Management of pediatric conditions including acute kidney injury, aspiration pneumonia, meningitis, and asthma-related complications.

These rotations strengthened Dr. Munir’s competencies in clinical assessment, pharmacotherapy optimization, medication safety, drug interaction management, and evidence-based clinical decision-making in hospital settings.

Research Methodology Expertise

Dr. Muhammad Zeeshan Munir has extensive experience in designing and conducting clinical and pharmacoepidemiological research using both experimental and observational study designs. His doctoral research integrated multiple quantitative and analytical methodologies to investigate pharmacological treatments and clinical outcomes among hospitalized patients.

His methodological expertise includes:

Systematic Reviews and Meta-Analysis

Experience in conducting systematic reviews of randomized controlled trials and observational studies, including evidence synthesis following internationally recognized reporting guidelines such as PRISMA.

Clinical Outcomes Research

Design and analysis of retrospective cohort studies evaluating demographic, clinical, and pharmacological determinants of patient outcomes, particularly in infectious diseases and hospital settings.

Survey-Based Research (KAP Studies)

Development and administration of structured questionnaires to assess knowledge, attitudes, and practices among healthcare professionals regarding drug-related problems and pharmacotherapy.

Pharmacoepidemiology and Drug Utilization Research

Evaluation of medication use patterns, treatment trajectories, and drug-related problems in clinical populations.

Evidence-Based Medicine

Application of evidence synthesis techniques to evaluate therapeutic interventions and inform clinical decision-making in healthcare settings.